Beyond Air® Appoints Dan Moorhead as Chief Financial Officer
XAIRGARDEN CITY, N.Y., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced the appointment of Dan Moorhead as Chief Financial Officer, effective January 5, 2026. Duke Dewrell, the Company's Controller, who had assumed CFO responsibilities at the Company on an interim basis in November 2025, will resume his prior role as of that date.
Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
XAIR(NASDAQ:XAIR) GARDEN CITY, N.Y., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, will participate in the H.C. Wainwright 27th Annual Global Investment Conference being held September 8-10, 2025 in New York, NY.
Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
XAIRRevenues increased 220% to $3.7 million, compared with $1.2 million for the fiscal year ended March 31, 2024
Beyond Air Receives U.S. Patent Covering Treatment of NTM Infections Using Gaseous Nitric Oxide
XAIRBeyond Air's NeuroNOS Subsidiary Receives FDA Orphan Drug Designation For Phelan-McDermid Syndrome
XAIRBeyond Air Releases Article In Annals Of The American Thoracic Society Journal Highlighting NTM-PD Patients' Ability To Safely Self-Administer High-Dose Intermittent iNO Treatments with LungFit GO At Home.
XAIRNeuroNOS Releases Research Publication By Its CSO Demonstrating Mechanism Of Action In Alzheimer's Disease
XAIRNeuroNOS Secures $2.0M Funding To Advance Development Of Autism Therapy
XAIRBeyond Air Expands Global Distribution Channels For LungFit PH With New Agreements
XAIRBeyond Air Option Alert: Jul 15 $10 Calls Sweep (8) near the Ask: 445 @ $0.65 vs 2351 OI; Earnings 6/9 After Close [est] Ref=$6.6399
XAIR